Business
Press Release Oct 22 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2021, titled " Zydus announces first patient randomised in EVIDENCES-XTM Phase II(b) clinical trial of Saroglitazar Mg in NASH ".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2021, titled \" Zydus announces first patient randomised in EVIDENCES-XTM Phase II(b) clinical trial of Saroglitazar Mg in NASH \". View Attachment","length":380,"tagName":"div"}]